Paralkar Lab, ribosome biogenesis, ribosome hematopoiesis, leukemia, transcription, epigenetics

Charles Antony, Post-Doctoral Researcher, is awarded a Co-Operative Center for Excellence in Hematology (CCEH) Type B grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to study transcription factor dynamics and regulation in primary human bone marrow.